Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of US patients with haemophilia and obesity (PwHO) and their partners and caregivers.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 6 10 2020
Statut: ppublish

Résumé

The ACTION study identified barriers to initiating and maintaining weight loss in patients with obesity; however, joint-related issues (pain, mobility and bleeding) may affect perceptions of patients with haemophilia and obesity (PwHO). To identify patient and caregiver insights on the unique challenges of PwHO. Following IRB approval, adults who self-identified as PwHO, spouses/partners of adult PwHO, and caregivers of adolescent PwHO (aged 12-17 years) completed an online survey between December 2017 and April 2018. Respondents included 124 adult PwHO, 45 spouses/partners and 42 caregivers. By calculated BMI, most adults were overweight (43%) or had obesity (51%); this differed from self-reported weight category. PwHO goals were improving health conditions (60%), having more energy (54%), reducing risks of weight (46%), and losing any weight (44%). Issues related to joint health were secondary for PwHO but frequently reported by spouses/parents. Most perceived weight loss to be a high priority (66%) and their responsibility (64%) but required a complete lifestyle change (63%). Most anticipated that weight loss would reduce joint pain (62%), bleeding (58%) and factor use (52%) and increase mobility (62%). Weight discussions with healthcare providers (HCPs) were commonly reported (51%). HCP discussions targeted improving health conditions (46%), achieving any weight loss (44%), being more active (73%) and improving eating habits (72%). Most PwHO (65%) perceived obesity as a disease and believe that 10% weight loss would be extremely beneficial (78%). In the past 5 years, 80% discussed being overweight and 68% losing weight; a minority reported being successful (9%) or somewhat successful (38%) with weight loss. More realistic or specific (51%/47%) goals, resources (46%), referrals to weight-loss programmes (41%) or dietitians (38%), meals or recipes (54%/50%), local or national (42%/41%) programmes for PwHO and success stories of PwHO (40%) are needed or would be helpful. PwHO, spouse/partners and caregivers exhibited awareness of general and haemophilia-specific consequences of excess body weight. Most have tried general approaches to improve eating and increase activity with little success and desire more education on weight management and more details on specific actionable recommendations distributed through existing haemophilia channels. These insights will better inform the creation of weight-loss programmes for this community.

Sections du résumé

BACKGROUND BACKGROUND
The ACTION study identified barriers to initiating and maintaining weight loss in patients with obesity; however, joint-related issues (pain, mobility and bleeding) may affect perceptions of patients with haemophilia and obesity (PwHO).
AIM OBJECTIVE
To identify patient and caregiver insights on the unique challenges of PwHO.
METHODS METHODS
Following IRB approval, adults who self-identified as PwHO, spouses/partners of adult PwHO, and caregivers of adolescent PwHO (aged 12-17 years) completed an online survey between December 2017 and April 2018.
RESULTS RESULTS
Respondents included 124 adult PwHO, 45 spouses/partners and 42 caregivers. By calculated BMI, most adults were overweight (43%) or had obesity (51%); this differed from self-reported weight category. PwHO goals were improving health conditions (60%), having more energy (54%), reducing risks of weight (46%), and losing any weight (44%). Issues related to joint health were secondary for PwHO but frequently reported by spouses/parents. Most perceived weight loss to be a high priority (66%) and their responsibility (64%) but required a complete lifestyle change (63%). Most anticipated that weight loss would reduce joint pain (62%), bleeding (58%) and factor use (52%) and increase mobility (62%). Weight discussions with healthcare providers (HCPs) were commonly reported (51%). HCP discussions targeted improving health conditions (46%), achieving any weight loss (44%), being more active (73%) and improving eating habits (72%). Most PwHO (65%) perceived obesity as a disease and believe that 10% weight loss would be extremely beneficial (78%). In the past 5 years, 80% discussed being overweight and 68% losing weight; a minority reported being successful (9%) or somewhat successful (38%) with weight loss. More realistic or specific (51%/47%) goals, resources (46%), referrals to weight-loss programmes (41%) or dietitians (38%), meals or recipes (54%/50%), local or national (42%/41%) programmes for PwHO and success stories of PwHO (40%) are needed or would be helpful.
CONCLUSIONS CONCLUSIONS
PwHO, spouse/partners and caregivers exhibited awareness of general and haemophilia-specific consequences of excess body weight. Most have tried general approaches to improve eating and increase activity with little success and desire more education on weight management and more details on specific actionable recommendations distributed through existing haemophilia channels. These insights will better inform the creation of weight-loss programmes for this community.

Identifiants

pubmed: 32017339
doi: 10.1111/hae.13918
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-19

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Références

Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of haemophilia. Haemophilia. 2013;19(1):e1-e47.
Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood. 2004;103(7):2467-2473.
Carpenter SL, Chrisco M, Johnson E. The effect of overweight and obesity on joint damage in patients with moderate or severe hemophilia. Blood. 2006;108(11):4064.
Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA. The longitudinal effect of body adiposity on joint mobility in young males with haemophilia A. Haemophilia. 2011;17(2):196-203.
Monahan PE, Baker JR, Riske B, Soucie JM. Physical functioning in boys with hemophilia in the US. Am J Prev Med. 2011;41(6 Suppl 4):S360-S368.
Biere-rafi S, Haak BW, Peters M, Gerdes VEA, Büller HR, Kamphuisen PW. The impairment in daily life of obese haemophiliacs. Haemophilia. 2011;17(2):204-208.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-S138.
Witkop M, Neff A, Buckner TW, et al. Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study. Haemophilia. 2017;23(4):556-565.
Kahan S, Cuker A, Kushner RF, et al. Prevalence and impact of obesity in people with haemophilia: review of literature and expert discussion around implementing weight management guidelines. Haemophilia. 2017;23(6):812-820.
Curtis R, Baker J, Riske B, et al. Young adults with hemophilia in the U.S.: demographics, comorbidities, and health status. Am J Hematol. 2015;90(suppl 2):S11-S16.
Lim MY, Pruthi RK. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coagul Fibrinolysis. 2011;22(5):402-406.
Majumdar S, Morris A, Gordon C, et al. Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi. Haemophilia. 2010;16(3):455-459.
McNamara M, Antun A, Kempton CL. The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study. Haemophilia. 2014;20(2):190-195.
Ullman M, Zhang QC, Brown D, Grant A, Soucie JM, Haemophilia Treatment Center Network Investigators. Association of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men. Haemophilia. 2014;20(3):340-348.
Ullman M, Du Treil KE, S, Moynihan K. Increased body mass index in persons with hemophilia. Am J Hematol. 2006;12(16);FP460.
Recht M, Lentz SR, Zupanic-Salek S, et al. Factor VIII dosing and preventive efficacy in obese patients with hemophilia (BMI>-30 kg m2) - a post-hoc sub-analysis of the guardian trials. Blood. 2014;124:1503.
Tuinenburg A, Biere-Rafi S, Peters M, et al. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters. Haemophilia. 2013;19(5):744-752.
Majumdar S, Ahmad N, Karlson C, Morris A, Iyer R. Does weight reduction in haemophilia lead to a decrease in joint bleeds? Haemophilia. 2012;18(3):e82-e84.
Yerrabothala S, McKernan L, Ornstein DL. Bariatric surgery in haemophilia. Haemophilia. 2016;22(3):e232-e234.
Majumdar S, Ostrenga A, Latzman RD, et al. Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution. Haemophilia. 2011;17(4):717-718.
Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: Results from the national ACTION study. Obesity (Silver Spring). 2018;26(1):61-69.
Barlow SE. Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4):S164-192.
Kelly AS, Barlow SE, Rao G, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation. 2013;128(15):1689-1712.
Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics. 2007;120(Suppl 4):S254-S288.
DeBoer MD, Filipp SL, Gurka MJ. Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents. Pediatr Obes. 2019;14(4):e12483.
Gurka MJ, Filipp SL, DeBoer MD. Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. Nutr Diabetes. 2018;8(1):14.
Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity - assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709-757.
Look Ahead Research Group, Wadden TA, West DS, et al. The Look Ahead study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14(5):737-752.
Look Ahead Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look Ahead study. Obesity (Silver Spring). 2014;22(1):5-13.
Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132(6):2226-2238.
August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an Endocrine Society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93(12):4576-4599.
Ruisi J. Body composition and health of children with hemophilia. OHSU Digital Commons. 2017. http://scholar.google.com/scholar_url?url=https%3A%2F%2Fpdfs.semanticscholar.org%2F7053%2Ff95e5a1ceace4b669f16337cd892146c595c.pdf&hl=en&sa=T&oi=ggp&ct=res&cd=0&d=9797974460286472959&ei=1sKpXYiXMomUyQSMiZLIAw&scisig=AAGBfm2Z5umR-f7nVj-FolFi9eeaymw09g&nossl=1&ws=1829x868&at=Body%20Composition%20and%20Health%20of%20Children%20with%20Hemophilia&bn=1. Accessed October 15, 2019

Auteurs

Stacy E Croteau (SE)

Boston Children's Hospital, Boston, Massachusetts.

Susan Cutter (S)

University of Pennsylvania, Philadelphia, Pennsylvania.

Grace Hernandez (G)

The Center for Inherited Blood Disorders, Orange, California.

Brian Wicklund (B)

Children's Mercy-Kansas City, Kansas City, Missouri.

Meredith L Dreyer Gillette (ML)

Children's Mercy-Kansas City, Kansas City, Missouri.

Kimberly Haugstad (K)

Hemophilia Federation of America, Washington, District of Columbia.

David L Cooper (DL)

Novo Nordisk Inc, Plainsboro, New Jersey.

Vlady Ostrow (V)

Novo Nordisk Inc, Plainsboro, New Jersey.

Joe Nadglowski (J)

Obesity Action Coalition, Tampa, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH